The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
BURNING ROCK BIOTECH LTD | SPONSORED ADS | 12233L107 | 1,662 | 174,403 | SH | SOLE | 0 | 0 | 174,403 | ||
I MAB | SPONSORED ADS | 44975P103 | 9,478 | 200,000 | SH | SOLE | 0 | 0 | 200,000 | ||
ZAI LAB LTD | ADR | 98887Q104 | 1,820 | 28,952 | SH | SOLE | 0 | 0 | 28,952 |